US equities
|
SPCX
$158.04
▲+6.94%
MU
$912.06
▲+1.78%
NVDA
$220.65
▲+1.93%
TSLA
$385.04
▲+3.03%
META
$703.25
▲+1.30%
SNDK
$1,376.81
▲+0.84%
AMD
$552.37
▲+3.30%
AAPL
$343.71
▲+1.24%
SPCX
$158.04
▲+6.94%
MU
$912.06
▲+1.78%
NVDA
$220.65
▲+1.93%
TSLA
$385.04
▲+3.03%
META
$703.25
▲+1.30%
SNDK
$1,376.81
▲+0.84%
AMD
$552.37
▲+3.30%
AAPL
$343.71
▲+1.24%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NASDAQ:ADAP
Recent news which mentions NASDAQ:ADAP
ADAP Stock Earnings: Adaptimmune Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 12, 2024
Tickers
ADAP
Tags
Earnings Reports
Market News
ADAP
From
InvestorPlace
ADAP Stock Earnings: Adaptimmune Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 15, 2024
Tickers
ADAP
Tags
Market News
Earnings Reports
NASDAQ:ADAP
From
InvestorPlace
ADAP Stock Earnings: Adaptimmune Therapeutics Misses EPS, Misses Revenue for Q4 2023
March 06, 2024
Tickers
ADAP
Tags
Market News
Today's Market
NASDAQ:ADAP
From
InvestorPlace